Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury
Background. Acute kidney injury (AKI) is a common and severe complication in patients with cirrhosis. Progression of AKI to a higher stage associates with increased mortality. Intervening early in AKI when renal dysfunction is worsening may improve outcomes. However, serum creatinine correlates poor...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | International Journal of Nephrology |
| Online Access: | http://dx.doi.org/10.1155/2014/708585 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563210821042176 |
|---|---|
| author | Justin M. Belcher Arun J. Sanyal Guadalupe Garcia-Tsao Naheed Ansari Steven G. Coca Michael G. Shlipak Chirag R. Parikh |
| author_facet | Justin M. Belcher Arun J. Sanyal Guadalupe Garcia-Tsao Naheed Ansari Steven G. Coca Michael G. Shlipak Chirag R. Parikh |
| author_sort | Justin M. Belcher |
| collection | DOAJ |
| description | Background. Acute kidney injury (AKI) is a common and severe complication in patients with cirrhosis. Progression of AKI to a higher stage associates with increased mortality. Intervening early in AKI when renal dysfunction is worsening may improve outcomes. However, serum creatinine correlates poorly with glomerular filtration in patients with cirrhosis and fluctuations may mask progression early in the course of AKI. Cystatin C, a low-molecular-weight cysteine proteinase inhibitor, is a potentially more accurate marker of glomerular filtration. Methods. We conducted a prospective multicenter study in patients with cirrhosis comparing changes in cystatin and creatinine immediately following onset of AKI as predictors of a composite endpoint of dialysis or mortality. Results. Of 106 patients, 37 (35%) met the endpoint. Cystatin demonstrated less variability between samples than creatinine. Patients were stratified into four groups reflecting changes in creatinine and cystatin: both unchanged or decreased 38 (36%) (Scr−/CysC−); only cystatin increased 25 (24%) (Scr−/CysC+); only creatinine increased 15 (14%) (Scr+/CysC−); and both increased 28 (26%) (Scr+/CysC+). With Scr−/CysC− as the reference, in both instances where cystatin rose, Scr−/CysC+ and Scr+/CysC+, the primary outcome was significantly more frequent in multivariate analysis, P=0.02 and 0.03, respectively. However, when only creatinine rose, outcomes were similar to the reference group. Conclusions. Changes in cystatin levels early in AKI are more closely associated with eventual dialysis or mortality than creatinine and may allow more rapid identification of patients at risk for adverse outcomes. |
| format | Article |
| id | doaj-art-399918f341f1441eb04db3ad9f61d8fc |
| institution | Kabale University |
| issn | 2090-214X 2090-2158 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Nephrology |
| spelling | doaj-art-399918f341f1441eb04db3ad9f61d8fc2025-02-03T01:20:41ZengWileyInternational Journal of Nephrology2090-214X2090-21582014-01-01201410.1155/2014/708585708585Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney InjuryJustin M. Belcher0Arun J. Sanyal1Guadalupe Garcia-Tsao2Naheed Ansari3Steven G. Coca4Michael G. Shlipak5Chirag R. Parikh6Program of Applied Translational Research, Yale University School of Medicine, New Haven, CT 06510, USADivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USAClinical Epidemiology Research Center, VAMC, West Haven, CT 06516, USADivision of Nephrology, Department of Internal Medicine, Jacobi Medical Center, South Bronx, NY 10461, USAProgram of Applied Translational Research, Yale University School of Medicine, New Haven, CT 06510, USADivision of General Internal Medicine, San Francisco VA Medical Center, University of California, San Francisco, CA 94121, USAProgram of Applied Translational Research, Yale University School of Medicine, New Haven, CT 06510, USABackground. Acute kidney injury (AKI) is a common and severe complication in patients with cirrhosis. Progression of AKI to a higher stage associates with increased mortality. Intervening early in AKI when renal dysfunction is worsening may improve outcomes. However, serum creatinine correlates poorly with glomerular filtration in patients with cirrhosis and fluctuations may mask progression early in the course of AKI. Cystatin C, a low-molecular-weight cysteine proteinase inhibitor, is a potentially more accurate marker of glomerular filtration. Methods. We conducted a prospective multicenter study in patients with cirrhosis comparing changes in cystatin and creatinine immediately following onset of AKI as predictors of a composite endpoint of dialysis or mortality. Results. Of 106 patients, 37 (35%) met the endpoint. Cystatin demonstrated less variability between samples than creatinine. Patients were stratified into four groups reflecting changes in creatinine and cystatin: both unchanged or decreased 38 (36%) (Scr−/CysC−); only cystatin increased 25 (24%) (Scr−/CysC+); only creatinine increased 15 (14%) (Scr+/CysC−); and both increased 28 (26%) (Scr+/CysC+). With Scr−/CysC− as the reference, in both instances where cystatin rose, Scr−/CysC+ and Scr+/CysC+, the primary outcome was significantly more frequent in multivariate analysis, P=0.02 and 0.03, respectively. However, when only creatinine rose, outcomes were similar to the reference group. Conclusions. Changes in cystatin levels early in AKI are more closely associated with eventual dialysis or mortality than creatinine and may allow more rapid identification of patients at risk for adverse outcomes.http://dx.doi.org/10.1155/2014/708585 |
| spellingShingle | Justin M. Belcher Arun J. Sanyal Guadalupe Garcia-Tsao Naheed Ansari Steven G. Coca Michael G. Shlipak Chirag R. Parikh Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury International Journal of Nephrology |
| title | Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury |
| title_full | Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury |
| title_fullStr | Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury |
| title_full_unstemmed | Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury |
| title_short | Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury |
| title_sort | early trends in cystatin c and outcomes in patients with cirrhosis and acute kidney injury |
| url | http://dx.doi.org/10.1155/2014/708585 |
| work_keys_str_mv | AT justinmbelcher earlytrendsincystatincandoutcomesinpatientswithcirrhosisandacutekidneyinjury AT arunjsanyal earlytrendsincystatincandoutcomesinpatientswithcirrhosisandacutekidneyinjury AT guadalupegarciatsao earlytrendsincystatincandoutcomesinpatientswithcirrhosisandacutekidneyinjury AT naheedansari earlytrendsincystatincandoutcomesinpatientswithcirrhosisandacutekidneyinjury AT stevengcoca earlytrendsincystatincandoutcomesinpatientswithcirrhosisandacutekidneyinjury AT michaelgshlipak earlytrendsincystatincandoutcomesinpatientswithcirrhosisandacutekidneyinjury AT chiragrparikh earlytrendsincystatincandoutcomesinpatientswithcirrhosisandacutekidneyinjury |